N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma

Abroad (travel likely)RecruitingPHASE2

Conditions

High-risk Neuroblastoma · Neuroblastoma · Childhood Neuroblastoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Study coordinator (Brian Kushner, MD) · 212-639-6793

Study leads

Brian Kushner, MD
Principal Investigator
Memorial Sloan Kettering Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Ganglioneuroblastoma, Nodular · Neuroblastoma

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Mobile, United States

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Ganglioneuroblastoma · Ganglioneuroblastoma, Nodular · Neuroblastoma

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Phoenix, United States

Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation

CNS Embryonal Tumor · CNS, Medulloblastoma · Atypical Teratoid Rhabdoid Tumor

Abroad (travel likely)RecruitingEARLY_PHASE1

Calgary, Canada · Vancouver, Canada

Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

Neuroblastoma

Abroad (travel likely)RecruitingPHASE2

Minneapolis, United States